Table 2.
Cycle characteristics of the mock and control groups
|
| |||||
| MOCK (n = 103) | Control (n = 92) | P-value | Relative risk (95% CI) | ||
| Protocol | |||||
| Long agonist | 4/103 (3.88) | 01/92 (1.09) | 0.25 | 3.5728 (0.4066-31.3931) | |
| Antagonist | 99/103 (96.12) | 91/92 (98.91) | 0.20 | 0.9717 (0.9296-1.0158 | |
| Insemination | |||||
| IVF | 47/103 (45.63) | 37/92 (40.22) | 0.44 | 1.1346 (0.8187-1.5725) | |
| ICSI | 32/103 (31.07) | 37/92 (40.22) | 0.18 | 0.7725 (0.5280-1.1302) | |
| Split | 24/103 (23.30) | 18/92 (19.57) | 0.52 | 1.1909 ( 0.6922-2.0490) | |
| Fresh | 5//97 (4.85) | 09/87 (10.34) | 0.16 | 0.4693 (0.1633-1.3481) | |
| Frozen | 92/97 (89.32) | 78/87 (89.66) | 0.94 | 0.9963 (0.9035-1.0986) | |
| Number of oocytes obtained* | 18 (5-64) | 15 (3-41) | 0.03 | ||
| Quality of embryos | |||||
| Top | 85/97 (91.75) | 76/87 (87.36) | 0.95 | 1.0031 (0.8991-1.1192) | |
| Average | 12/97 (12.37) | 11/87 (12.64) | 0.95 | 0.9784 (0.4552-2.1032) | |
| Number of transferred embryos | |||||
| 0 | 6/103 (5.83) | 05/92 (5.43) | 0.90 | 1.0718 (0.3384-3.3954) | |
| 1 | 71/103 (68.93) | 60/92 (65.22) | 0.58 | 1.0570 (0.8674-1.2880) | |
| 2 | 26/103 (25.24) | 26/92 (28.26) | 0.63 | 0.8932 (0.5609-1.4223) | |
| 3 | 0/103 (0 ) | 01/92 (1.09) | 0.45 | 0.2981 (0.0123-7.2284) | |
| Actual transfer | |||||
| Easy | 96/97 (98.97) | 87/87 (100) | 0.31 | 0.9897 (0.9698-1.0100) | |
| Difficult | 01/97 (1.03) | 0/87 (0) | 0.54 | 2.6939 (0.1112-65.2795) | |
| Catheter tip bleeding | 04/97 (4.12) | 04/87 (4.60) | 0.87 | 0.8969 (0.2313-3.4784) | |
| Catheter tip mucus | 07/97 (7.22) | 06/87 (6.90) | 0.93 | 1.0464 (0.3657-2.9942) | |
| Consultant | 37/97 (38.14) | 36/87 (41.38) | 0.65 | 0.9218 (0.6457-1.3161) | |
| Registrar | 60/97 (61.86) | 51/87 (58.62) | 0.65 | 1.0552 (0.8335-1.3358) | |
| Data presented as n (%). P-value refer to Chi-squared test; when appropriate, P-value 0.05 was considered as significant. * independent t test, IVF: In vitro fertilisation, ICSI: Intracytoplasmic sperm injection | |||||